Primary literature evidence

Experimental evidence search

Search paper-level observations with their value, target, assay, evidence sentence, source location, and stable record links. Evidence without a safely standardized sequence remains visible without being misrepresented as a canonical peptide.

Evidence records

5,503 results

ImmunomodulatoryAnti-inflammatoryPositive observation

Section 2.10: 20 μg/mL of Hydrostatin-AMP2 could reduce iNOS expression by 87.5%.

Mention PMC10004598::PEP000001PMC10004598text

Measure: percent_inhibition
Value: 87.5%
Target: Mus musculus
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: LR5 at 12.5 μg/mL, NO Inhibition Rate = 19.73 ± 0.39%.

Mention PMC10221837::PEP000001PMC10221837table

Measure: percent_inhibition
Value: 19.73 ± 0.39%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: LR5 at 25 μg/mL, NO Inhibition Rate = 15.98 ± 0.22%.

Mention PMC10221837::PEP000001PMC10221837table

Measure: percent_inhibition
Value: 15.98 ± 0.22%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: LR5 at 50 μg/mL, NO Inhibition Rate = 11.05 ± 0.08%.

Mention PMC10221837::PEP000001PMC10221837table

Measure: percent_inhibition
Value: 11.05 ± 0.08%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: LR5 at 100 μg/mL, NO Inhibition Rate = 8.79 ± 0.39%.

Mention PMC10221837::PEP000001PMC10221837table

Measure: percent_inhibition
Value: 8.79 ± 0.39%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: AR5 at 12.5 μg/mL, NO Inhibition Rate = 12.36 ± 0.12%.

Mention PMC10221837::PEP000002PMC10221837table

Measure: percent_inhibition
Value: 12.36 ± 0.12%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: AR5 at 25 μg/mL, NO Inhibition Rate = 6.76 ± 0.11%.

Mention PMC10221837::PEP000002PMC10221837table

Measure: percent_inhibition
Value: 6.76 ± 0.11%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: AR5 at 50 μg/mL, NO Inhibition Rate = 9.31 ± 0.15%.

Mention PMC10221837::PEP000002PMC10221837table

Measure: percent_inhibition
Value: 9.31 ± 0.15%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: AR5 at 100 μg/mL, NO Inhibition Rate = 8.80 ± 0.11%.

Mention PMC10221837::PEP000002PMC10221837table

Measure: percent_inhibition
Value: 8.80 ± 0.11%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: LAR5 at 12.5 μg/mL, NO Inhibition Rate = 13.84 ± 0.04%.

Mention PMC10221837::PEP000003PMC10221837table

Measure: percent_inhibition
Value: 13.84 ± 0.04%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: LAR5 at 25 μg/mL, NO Inhibition Rate = 13.51 ± 0.04%.

Mention PMC10221837::PEP000003PMC10221837table

Measure: percent_inhibition
Value: 13.51 ± 0.04%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: LAR5 at 50 μg/mL, NO Inhibition Rate = 11.05 ± 0.04%.

Mention PMC10221837::PEP000003PMC10221837table

Measure: percent_inhibition
Value: 11.05 ± 0.04%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: LAR5 at 100 μg/mL, NO Inhibition Rate = 7.72 ± 0.08%.

Mention PMC10221837::PEP000003PMC10221837table

Measure: percent_inhibition
Value: 7.72 ± 0.08%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: YR6 at 12.5 μg/mL, NO Inhibition Rate = 14.51 ± 0.15%.

Mention PMC10221837::PEP000004PMC10221837table

Measure: percent_inhibition
Value: 14.51 ± 0.15%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: YR6 at 25 μg/mL, NO Inhibition Rate = 17.81 ± 0.34%.

Mention PMC10221837::PEP000004PMC10221837table

Measure: percent_inhibition
Value: 17.81 ± 0.34%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: YR6 at 50 μg/mL, NO Inhibition Rate = 10.46 ± 0.09%.

Mention PMC10221837::PEP000004PMC10221837table

Measure: percent_inhibition
Value: 10.46 ± 0.09%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: YR6 at 100 μg/mL, NO Inhibition Rate = 5.65 ± 0.37%.

Mention PMC10221837::PEP000004PMC10221837table

Measure: percent_inhibition
Value: 5.65 ± 0.37%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: AGR6 at 12.5 μg/mL, NO Inhibition Rate = 8.04 ± 0.15%.

Mention PMC10221837::PEP000005PMC10221837table

Measure: percent_inhibition
Value: 8.04 ± 0.15%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: AGR6 at 25 μg/mL, NO Inhibition Rate = 19.04 ± 0.04%.

Mention PMC10221837::PEP000005PMC10221837table

Measure: percent_inhibition
Value: 19.04 ± 0.04%
Target: RAW264.7
Assay: Not reported by source

Source publication

ImmunomodulatoryAnti-inflammatoryNegative / threshold

Table 1: AGR6 at 50 μg/mL, NO Inhibition Rate = 8.93 ± 0.07%.

Mention PMC10221837::PEP000005PMC10221837table

Measure: percent_inhibition
Value: 8.93 ± 0.07%
Target: RAW264.7
Assay: Not reported by source

Source publication

Names such as P1, PEP1, or peptide 1 are paper-local labels. Search results group them by publication and never assume cross-paper molecular identity without sequence or explicit structural evidence.